Impact of the COVID-19 pandemic on cancer care in OECD countries

OECD health working papers, Journal Year: 2022, Volume and Issue: unknown

Published: May 5, 2022

The COVID-19 pandemic has disrupted primary and secondary prevention efforts as well routine cancer care including diagnosis treatment. number of cancer-related procedures declined across countries. Many the OECD countries also faced challenges in maintaining further improving quality outcomes during pandemic. This paper compiles initial findings from a subset covering period March 2020 to August 2021. It illustrates how several these attempted mitigate impact on systems. There have been examples adapting treatment guidelines, changing clinical practices reducing backlogs minimise negative impacts patients. Several undertook more frequent monitoring in-depth analysis performance. analyses confirm that strong health information infrastructure is crucial for developing resilient systems provide effective, timely people-centred care.

Language: Английский

---

Delivery of Cancer Care in Ontario, Canada, During the First Year of the COVID-19 Pandemic

JAMA Network Open, Journal Year: 2022, Volume and Issue: 5(4), P. e228855 - e228855

Published: April 25, 2022

Importance

The COVID-19 pandemic has impacted cancer systems worldwide. Quantifying the changes is critical to informing delivery of care while continues, as well for system recovery and future planning.

Objective

To quantify change in services across continuum during pandemic.

Design, Setting, Participants

This population-based cohort study assessed screening, imaging, diagnostic, treatment, psychosocial oncological delivered pediatric adult populations Ontario, Canada (population 14.7 million), from April 1, 2019, March 2021. Data were analyzed May 1 July 31,

Exposures

Main Outcomes Measures

Cancer service volumes first year pandemic, defined 2020, 2021, compared with a prepandemic period 2020.

Results

During there total 4 476 693 services, 5 644 105 prior, difference 20.7% fewer care, representing potential backlog 167 412 services. While less pronounced systemic treatments, emergency urgent imaging examinations (eg, 1.9% more parenteral treatments) surgical procedures 65% procedures), major reductions observed most beginning Compared year, screenings reduced by 42.4% (−1 016 181 screening tests), treatment 14.1% (−8020 radiation visits 21.0% (−141 629 visits). Biopsies confirm decreased up 41.2% resections 27.8% wave. New consultation also decreased, such (−8.2%) (−9.3%). use virtual increased visits, increasing 0% 20% new or follow-up prior 78% year.

Conclusions Relevance

In this Canada, large observed. recovered levels at end substantial deficit likely accrued. anticipated downstream morbidity mortality associated underscore need address recover warrant further study.

Language: Английский

---

Evaluating the impact of the COVID-19 pandemic on cancer screening in a central Canadian province

Preventive Medicine, Journal Year: 2022, Volume and Issue: 155, P. 106961 - 106961

Published: Jan. 19, 2022

We evaluated the impact of COVID-19 on cancer screening in Manitoba, Canada using an interrupted time series (ITS) design and data from Manitoba's population-based, organized programs April 2020 to August 2021. In June (breast was suspended during May 2020), there a 54% decrease between predicted (i.e., observed produced regression models) expected counterfactual values for period by assuming did not occur) number mammograms (ratio = 0.46, 95% Confidence Interval (CI) 0.28–0.64). By December 2020, no significant difference 0.95, CI 0.80–1.10). 83% Pap tests 0.17, 0.04–0.30). January 2021, 0.93, 0.81–1.06). 81% program fecal occult blood (FOBTs) 0.19, 0.0–0.44). September FOBTs 0.65–1.24). The estimated cumulative deficit backlog) 2021 17,370 mammograms, 22,086 tests, 5253 FOBTs. Overall, adapted quickly pandemic. Additional strategies may be needed address remaining backlogs.

Language: Английский

---

Assessing the impact of the COVID-19 pandemic on breast cancer screening and diagnosis rates: A rapid review and meta-analysis

Journal of Medical Screening, Journal Year: 2022, Volume and Issue: 29(4), P. 209 - 218

Published: May 20, 2022

Objective The ongoing COVID-19 pandemic has caused an indefinite delay to cancer screening programs worldwide. This study aims explore the impact on breast outcomes such as mammography and diagnosis rates. Methods We searched Ovid MEDLINE, Embase, medRxiv bioRxiv between January 2020 October 2021 identify studies that reported rates of before during pandemic. effects ‘lockdown’ measures, age ethnicity were also examined. All assessed for risk bias using Newcastle-Ottawa Scale (NOS). Rate ratios calculated all pooled standard inverse-variance random meta-analysis. Results identified 994 articles, which 7 registry-based 24 non-registry-based retrospective cohort studies, including data 4,860,786 629,823 patients respectively across 18 different countries, identified. Overall, dropped by estimated 41–53% 18–29% 2019 2020. No differences in mammogram depending patient or observed. However, countries implemented lockdown measures associated with a significantly greater reduction comparison those did not. Conclusion substantial cancer, reductions more pronounced under restrictions. It is early yet know if delayed translates into higher mortality.

Language: Английский

---

Effects of the COVID‐19 pandemic on gastroenterological surgeries in 2020: A study using the National Clinical Database of Japan

Annals of Gastroenterological Surgery, Journal Year: 2022, Volume and Issue: 7(3), P. 407 - 418

Published: Nov. 18, 2022

Abstract Aim This study aimed to investigate the effect of coronavirus disease pandemic on number surgeries for gastroenterological cancer cases in Japan. Methods The data recorded National Clinical Database Japan between 2018 and 2020 were utilized this study. Five specific primary cancers surgery acute diffuse peritonitis considered endpoints. We divided period into prepandemic postpandemic (after April 2020) periods examined relation clinical factors. Results Overall, 228 860 analyzed. Among five surgeries, distal gastrectomies gastric decreased most (to 81.0% monthly period), followed by that low anterior resections rectal (91.4%). In contrast, pancreaticoduodenectomies pancreatic increased 7.1%, while remained stable. trend was observed nationwide. also noted a marked reduction gastrectomy 72.5%), resection (84.0%), esophagectomy (88.8%) procedures T1 tumors. noncurative rate mortalities despite proportion T4 tumors older patients. Conclusion A with early T factors may reflect prioritization screenings. Although quality maintained terms reduced morbidities, long‐term effects should be monitored.

Language: Английский

---

Impact of COVID-19 pandemic on breast and cervical cancer screening in Denmark: A register-based study

eLife, Journal Year: 2023, Volume and Issue: 12

Published: March 21, 2023

Denmark was one of the few countries where it politically decided to continue cancer screening during COVID-19 pandemic. We assessed actual population uptake mammography and cervical this period.The first lockdown in announced on 11 March 2020. To investigate possible changes activity due pandemic, we analysed data from beginning 2017 until end 2021. A time series analysis carried out discover trends outliers activities period 2017-2021. Data were retrieved governmental pandemic-specific monitoring health care activities.A brief drop seen right after lockdown, but quickly returned its previous level. short-term deficit 43% [CI -49 -37] found for screening. 62% -65 -58] Furthermore, a slight, statistically significant downward trend 2018 2021 probably unrelated Other changes, example, marked towards 2021, also seem pandemic.Denmark continued following temporary breast activity.Region Zealand (R22-A597).

Language: Английский

---

Evaluating and Improving Cancer Screening Process Quality in a Multilevel Context: The PROSPR II Consortium Design and Research Agenda

Cancer Epidemiology Biomarkers & Prevention, Journal Year: 2022, Volume and Issue: 31(8), P. 1521 - 1531

Published: May 17, 2022

Abstract Background: Cancer screening is a complex process involving multiple steps and levels of influence (e.g., patient, provider, facility, health care system, community, or neighborhood). We describe the design, methods, research agenda Population-based Research to Optimize Screening Process (PROSPR II) consortium. PROSPR II Centers (PRC), Coordinating Center aim identify opportunities improve processes reduce disparities through investigation factors affecting cervical, colorectal, lung cancer in U.S. community settings. Methods: collected multilevel, longitudinal data from clinical administrative sources on >9 million racially ethnically diverse individuals across 10 heterogeneous systems with cohorts beginning January 1, 2010. To facilitate comparisons organ types highlight breadth, we calculated frequencies multilevel characteristics volumes diagnostic tests/procedures abnormalities. Results: Variations facility reflected differing target populations. PRCs identified incident diagnoses invasive cancers, situ precancers (invasive: 372 24,131 11,205 lung; situ: 911 32 precancers: 13,838 554,499 colorectal). Conclusions: II's aims advance: (i) conceptualization measurement process, its factors, quality; (ii) knowledge disparities; (iii) evaluation COVID-19 pandemic's initial impacts screening. invite researchers collaborate investigators. Impact: valuable resource for researchers.

Language: Английский

---

Association between health insurance coverage and stage of diagnosis for cervical Cancer among females in Indiana from 2011 - 2019

Preventive Medicine Reports, Journal Year: 2025, Volume and Issue: 50, P. 102975 - 102975

Published: Jan. 13, 2025

Health insurance status is an important determinant of health outcomes for patients with cancer. This study aimed to assess the extent which coverage in Indiana a contributing factor stage cervical cancer diagnosis. We examined reported cases among females (N = 2518) using registry data from Department 2011 2019. Analyses were carried out SPSS. Using multinomial logistic regression, we associations both and race/ethnicity diagnosis after adjusting age at The analysis showed that uninsured (OR 2.42, 95 % CI 1.35-4.35) those who have Medicaid 2.36, 1.62-3.42) significantly more likely be diagnosed regional than in-situ compared private insurance. Additionally, Black 1.98, 1.21-3.24) Hispanic 2.19, %CI 1.04-4.61) when Non-Hispanic White females. Females are 4.43, 2.23-8.44) 3.03, 1.91-4.80) distant in-situ, Insurance associated later stages Increased routine screening preventive care services recommended, especially racial/ethnic minority populations, public

Language: Английский

---

COVID-19 and cancer screening in Scotland: A national and coordinated approach to minimising harm

Preventive Medicine, Journal Year: 2021, Volume and Issue: 151, P. 106606 - 106606

Published: June 30, 2021

Language: Английский

---

Assessing the global implications of the COVID-19 pandemic on the cervical cancer elimination initiative

PLOS Global Public Health, Journal Year: 2025, Volume and Issue: 5(4), P. e0004419 - e0004419

Published: April 28, 2025

The COVID-19 pandemic disrupted many public health programs; understanding these disruptions is critical for directing future resources. In a project studying the implementation of human papillomavirus (HPV) testing-based cervical cancer screening, we queried about impact on screening programs globally. consultation with World Health Organization’s Regional Advisors, program managers, government officials, and clinicians involved in HPV were invited to participate semi-structured, in-depth, interviews. Interview notes transcripts used inductive analysis, focusing responses programs. Thirty-two interviews conducted participants between age 29 61 years, representing from 25 countries. Six key themes noted. Regarding disruptions, (1) entire continuum was affected, leading delays or, some cases even cessation vaccination, treatment (2) heightened sense fear around contracting transmitting shifted priorities impacted healthcare delivery. Nonetheless, noted constructive ways which leveraged pandemic: at community level, able leverage an increased acceptance surrounding importance preventive behaviors; HPV-testing: molecular laboratories became well-equipped better technician training, increasing overall HPV-testing capacities; (3) promoted virtual systems; (4) planning: shutdowns allowed time plan scale-up. ways, response provided evidence supporting countries’ abilities mobilize While noted, implementers opportunities strengthen programs, should be further assessed sustainability research prevention control.

Language: Английский

---